B. Riley Financial Announces Preferred Stock Dividend Details
B. Riley Financial Declares Preferred Stock Dividends
B. Riley Financial, Inc. (NASDAQ: RILY) has recently made a noteworthy announcement regarding its cash dividends for preferred shareholders. This decision underscores the company’s commitment to its investors and reflects its solid financial position.
Overview of Preferred Stock Dividends
The company has declared dividends on its two classes of preferred stock: the 6.875% Series A Cumulative Perpetual Preferred Stock and the 7.375% Series B Cumulative Perpetual Preferred Stock. Each series is associated with depositary shares, offering holders a fractional interest in the designated stock.
Details of the Dividend Payments
For the 6.875% Series A Preferred Stock, the cash dividend amounts to $0.42968750 per depositary share. In contrast, holders of the 7.375% Series B Preferred Stock will receive a cash dividend of $0.4609375 per depositary share. This structured dividend payout indicates B. Riley's dedication to maintaining shareholder value.
Dividend Payment Dates
The scheduled payment date for these preferred stock dividends is set for October 31, 2024. Shareholders will need to be on record by the close of business on October 28, 2024, to qualify for these dividends. This timeline is crucial for investors to keep in mind to ensure their eligibility for the upcoming payments.
About B. Riley Financial
B. Riley Financial is a multifaceted financial services platform that offers customized solutions to meet its clients' various needs. The firm excels in providing comprehensive and collaborative services that span the entirety of the business lifecycle. B. Riley serves its clients through a network of affiliated subsidiaries, delivering end-to-end solutions across multiple sectors such as investment banking, private wealth management, and corporate restructuring.
Investment Strategy
B. Riley opportunistically invests to enhance shareholder value and actively engages in underwriting senior secured loans tailored for companies rich in assets. This strategic approach aligns with the company’s goal to provide robust support and attractive opportunities within the financial landscape.
Contact Information
For further inquiries, B. Riley Financial can be reached via their investor relations channel at ir@brileyfin.com or their media contact at press@briley.com.
Frequently Asked Questions
What are the key details of B. Riley Financial's preferred stock dividends?
B. Riley Financial has declared dividends of $0.42968750 for the Series A and $0.4609375 for the Series B preferred stock.
When will the preferred stock dividends be paid?
The dividends will be payable on or about October 31, 2024, to shareholders of record by October 28, 2024.
How does B. Riley Financial support its investors?
The company provides a diversified array of financial services and actively invests to benefit its shareholders.
What services does B. Riley Financial provide?
Its services include investment banking, corporate restructuring, risk management, financial consulting, and more, aimed at meeting clients' diverse needs.
How can I contact B. Riley Financial for more information?
Interested parties can reach out to B. Riley Financial via their investor relations email or media contact provided above.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Understanding Investor Sentiment for United Rentals Stock
- Progress Software Achieves Record Stock High of $67.5 Amid Growth
- Teleperformance Stock Upgrade: Market Potential Rising
- Aritzia's Expansion Fuels Optimism Despite Stock Fluctuations
- J.B. Hunt's Strong Positioning Amid Challenges and Opportunities
- SAIH Stock Reaches New Heights Amidst Market Optimism
- Stock Market Update: Positive Close in Sweden Amid Sector Gains
- Insights from David Einhorn on Buffett’s Recent Stock Moves
- SiriusXM Holdings Stock Gains: Insights and Investing Tips
- Mesabi Trust Achieves New Milestone with Stock Surge
Recent Articles
- Exscientia and Sanofi Drive Breakthroughs in Drug Development
- Impact of Bridge Closures on Freight Movement in the U.S.
- BioLineRx Strengthens Patent Protection for Motixafortide
- Evolution Petroleum: A Bright Future Amidst Market Changes
- Ardagh Metal Packaging Expands its Renewable Energy Initiative
- Cyngn's Latest Patent Strengthens AV Decision-Making Technology
- Celebrating Leadership: Tabatha Snow Named Top Dental Manager
- B. Riley Financial Announces Strategic Cash Dividend Plans
- Adicet Bio Expands Phase 1 Trials for Autoimmune Treatment
- Versiti Partners with Velico to Advance Blood Health Solutions
- OKYO Pharma Unveils Phase 2 Trial Recruitment for Ocular Pain Relief
- Georgia-Pacific Building Products Rejoins EIFS Industry Association
- BioLineRx Strengthens Market Position with New Cancer Drug Patent
- Techem's Impressive ESG Risk Rating Positions Them for Success
- Freeport McMoRan Adjusts Copper Sales Amid Production Setbacks
- Bystronic AG's Strategic Response to 2024 Sales Decline
- Synchrony Financial Achieves Impressive Earnings Performance
- Formycon's FYB206: A Promising Biosimilar for Keytruda
- Key Insights for Q3 Earnings Season in European Markets
- U.S. Bancorp Surprises with Strong Earnings Despite Revenue Dip
- British American Tobacco Set to Introduce Synthetic Nicotine Pouches
- Citizens Financial Group Reports Earnings Amid Revenue Challenges
- Strategic Stock Moves: Buy Occidental and Microsoft, Sell DG
- Pharvaris to Showcase Deucrictibant Research at Leading Conferences
- Elon Musk's Campaign Talks in Pennsylvania Emphasize Free Speech
- Sagimet Biosciences' Key Presentations at Liver Meeting 2024
- Opthea Announces Annual General Meeting and Leadership Changes
- Apellis to Showcase VALIANT Study Insights at ASN Kidney Week
- Discovering Top-Rated Stocks: First Solar and Clearway Energy
- Orally Disintegrating Tablets Set for Remarkable Growth Ahead
- Qualcomm's Strategic Decision: Waiting for Post-Election Insights
- Hydreight Technologies Reports Impressive Growth and Revenue Surge
- Introducing ECOTRIA CLARO 300: A New Era in Sustainable Packaging
- Green Ammo Secures Vital Defense Contracts Amid Shortages
- Perspective Therapeutics Enhances Production Capabilities
- Main Street Capital Solidifies Position with New $41.4 Million Deal
- Scilex Holding Explores Strategies for Enhancing Subsidiary Value
- Gyrodyne Celebrates Legal Victory for Flowerfield Development
- B. Riley Financial Announces Cash Dividends for Preferred Stock
- Apellis Presents Findings on Pegcetacoplan at ASN Kidney Week
- EyePoint Pharmaceuticals Expands Staff with Inducement Grants
- Criteo Set to Reveal Third Quarter Financial Insights
- Innovative Biotech Company Apogee Therapeutics to Showcase New Data
- CLN-978's FDA Clearance Marks a New Era for Autoimmune Treatment
- Square Honors Canadian Businesses Among Global Leaders
- Ardagh Metal Packaging's Strategic Move into Renewable Energy
- Invivyd Showcases PEMGARDA™ Advances at IDWeek 2024
- Freightos Achieves Milestones in Q3 with Outstanding Growth
- CI Global Asset Management Highlights October 2024 ETF Distributions
- Invivyd Set to Showcase PEMGARDA™ Findings at Upcoming Event